GO:0031501 mannosyltransferase complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031501 mannosyltransferase complex is a cellular component defined as a complex that possesses mannosyltransferase activity.
• The best structurally characterized example is the eukaryotic protein O-mannosyltransferase Pmt1-Pmt2 complex, which transfers mannose from dolichyl phosphate mannose to serine/threonine residues of target proteins.
• Mannosyltransferase complexes include O-mannosyltransferases, GPI mannosyltransferases, dolichol-phosphate mannose synthases, and bacterial glycolipid mannosyltransferases [4,5,6,8].
• O-mannosylation of dystroglycan by the Pmt1-Pmt2 complex is required for sarcolemma resilience and skeletal muscle health.
• DPM1, a component of the dolichol-phosphate mannose synthase complex, modulates desmosomal adhesion and epidermal differentiation through SERPINB5.
• Mannosyltransferase complexes are implicated in muscular dystrophy, epidermal disorders, fungal pathogenesis, and mycobacterial cell wall biosynthesis [5,6,7,8].
Description
The mannosyltransferase complex (GO:0031501) is a cellular component defined by its possession of mannosyltransferase activity, the enzymatic transfer of mannose from a donor substrate to an acceptor molecule. These complexes are found across eukaryotes and prokaryotes and participate in diverse glycosylation pathways, including protein O-mannosylation, glycosylphosphatidylinositol (GPI) anchor biosynthesis, and glycolipid assembly [4,6,8]. The structural and mechanistic understanding of these complexes has advanced significantly, with the eukaryotic Pmt1-Pmt2 complex being a paradigm for understanding how mannosyltransferases recognize substrates and catalyze mannose transfer. Mannosyltransferase complexes are critical for normal physiology. In humans, O-mannosylation of dystroglycan by the Pmt1-Pmt2 complex is essential for sarcolemma integrity and skeletal muscle function. Defects in dolichol-phosphate mannose synthase, which contains DPM1, lead to desmosomal adhesion defects and impaired epidermal differentiation. In pathogens, mannosyltransferase complexes such as the Candida glabrata GPI mannosyltransferase I complex and the mycobacterial PimE mannosyltransferase are attractive targets for antifungal and antimycobacterial drug development [6,8]. For researchers, GO:0031501 provides a unifying annotation for proteins that form complexes to execute mannosyltransferase reactions. Understanding the composition, assembly, and regulation of these complexes is essential for dissecting glycosylation pathways, modeling human disease, and developing therapeutic interventions [4,5,7].
mannosyltransferase complex At A Glance
| GO ID | GO:0031501 |
|---|---|
| GO term | mannosyltransferase complex |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Catalysis of mannose transfer from a donor substrate to an acceptor molecule |
| Example complex | Pmt1-Pmt2 protein O-mannosyltransferase complex |
| Substrates | Dolichyl phosphate mannose, GDP-mannose, proteins, lipids, glycolipids [4,6,8] |
| Associated diseases | Muscular dystrophy, epidermal differentiation disorders, fungal infections, mycobacterial pathogenesis [5,6,7,8] |
| Research methods | Cryo-EM, X-ray crystallography, knockout models, glycosylation assays [4,5,6,7,8] |
What Is GO:0031501?
According to the Gene Ontology, GO:0031501 mannosyltransferase complex is a cellular component defined as a complex that possesses mannosyltransferase activity. This means the complex as a whole catalyzes the transfer of mannose from a donor molecule, typically dolichyl phosphate mannose or GDP-mannose, to a specific acceptor such as a protein serine/threonine residue, a lipid, or an oligosaccharide [4,6,8]. The term encompasses hetero-oligomeric and homo-oligomeric assemblies whose primary biochemical function is mannose transfer [4,6].
Why Is mannosyltransferase complex Important in Cell Biology?
Mannosyltransferase complexes are central to glycosylation, a fundamental post-translational modification that affects protein folding, stability, and cell-cell interactions [4,7]. The Pmt1-Pmt2 complex is the only known protein O-mannosyltransferase in eukaryotes and is essential for O-mannosylation of dystroglycan, a modification required for sarcolemma resilience and skeletal muscle health. Mutations in genes encoding mannosyltransferase complex components or their substrates cause human diseases, including muscular dystrophy and epidermal disorders [5,7]. In pathogens, mannosyltransferase complexes are critical for cell wall integrity and virulence, making them promising drug targets [6,8]. Thus, studying GO:0031501 advances both basic glycobiology and translational medicine.
• Mannosyltransferase complexes catalyze O-mannosylation of dystroglycan, which is essential for sarcolemma integrity and skeletal muscle function.
• DPM1, a component of the dolichol-phosphate mannose synthase complex, regulates desmosomal adhesion and epidermal differentiation through SERPINB5.
• The Pmt1-Pmt2 complex is a model for understanding substrate recognition and catalysis in protein O-mannosylation.
• Candida glabrata GPI mannosyltransferase I complex is a potential antifungal target.
• Mycobacterial PimE mannosyltransferase is involved in glycolipid biosynthesis and cell wall formation, representing a tuberculosis drug target.
• Defects in mannosyltransferase complexes are linked to congenital muscular dystrophies and skin fragility disorders [5,7].
• Mannosyltransferase complexes are required for GPI anchor biosynthesis, which anchors many cell surface proteins.
• Studying these complexes informs glycosylation engineering and biotherapeutic production.
• Knockout and point-mutation models of mannosyltransferase genes reveal tissue-specific functions [5,7].
• Structural studies of mannosyltransferase complexes guide rational inhibitor design [4,6,8].
Mannosyltransferase complex: Components, Assembly and Research Methods
What Happens During mannosyltransferase complex?
In simple terms: The complex grabs a mannose sugar from a carrier molecule and attaches it to a target protein or lipid.
The mannosyltransferase complex catalyzes the transfer of mannose from a donor substrate, such as dolichyl phosphate mannose or GDP-mannose, to an acceptor molecule [4,6,8]. In protein O-mannosylation, the Pmt1-Pmt2 complex transfers mannose to serine or threonine residues of target proteins, initiating O-mannosyl glycan synthesis. In GPI anchor biosynthesis, GPI mannosyltransferase I adds mannose to phosphatidylinositol, a step essential for anchor maturation. In mycobacteria, PimE mannosyltransferase transfers mannose to glycolipid precursors during cell wall biosynthesis.
Substrate recognition and binding
In simple terms: The complex must recognize and bind both the mannose donor and the correct target molecule.
Structural studies of the Pmt1-Pmt2 complex reveal that Pmt1 and Pmt2 form a heterodimer with a conserved catalytic domain that binds dolichyl phosphate mannose and positions the acceptor peptide for transfer. The complex exhibits specificity for serine/threonine residues within particular sequence contexts, ensuring selective O-mannosylation of target proteins such as dystroglycan [4,7]. In Candida glabrata, the GPI mannosyltransferase I complex similarly recognizes phosphatidylinositol and GDP-mannose to catalyze mannose transfer.
Catalysis and product formation
In simple terms: Once substrates are bound, the complex performs the chemical reaction that links mannose to the target.
The catalytic mechanism involves activation of the mannose donor and nucleophilic attack by the acceptor hydroxyl group, resulting in the formation of a mannosidic linkage [4,8]. For Pmt1-Pmt2, the reaction produces O-mannosylated proteins, which are further elongated by other glycosyltransferases to form mature O-mannosyl glycans. In mycobacteria, PimE catalyzes the addition of mannose to glycolipids, contributing to the mannan core of the cell wall.
Assembly and stoichiometry
In simple terms: The complex is built from multiple protein subunits that must come together in the right proportions.
The Pmt1-Pmt2 complex is a heterodimer, with both subunits required for optimal activity and stability. The dolichol-phosphate mannose synthase complex includes DPM1, DPM2, and DPM3 subunits, and its assembly is essential for mannose donor synthesis. The Candida glabrata GPI mannosyltransferase I complex is a multi-subunit assembly whose structure has been resolved, revealing how subunits coordinate to form a functional enzyme.
Regulation of complex activity
In simple terms: Cells control when and where the complex works to meet changing needs.
Mannosyltransferase complex activity can be regulated at the level of subunit expression, post-translational modification, and availability of donor substrates [4,5]. For example, DPM1 levels influence desmosomal adhesion and epidermal differentiation, suggesting that the dolichol-phosphate mannose synthase complex is regulated during differentiation. In pathogens, mannosyltransferase complexes are regulated in response to host environment and stress, contributing to virulence [6,8].
Key Genes Involved in GO:0031501 mannosyltransferase complex
The following genes encode subunits or associated proteins of mannosyltransferase complexes across species.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POMT1 | Protein O-mannosyltransferase 1, catalytic subunit of Pmt1-Pmt2 complex | Mutations cause Walker-Warburg syndrome; knockout models show defective dystroglycan O-mannosylation [4,7] |
| POMT2 | Protein O-mannosyltransferase 2, partner subunit of Pmt1-Pmt2 complex | Required for Pmt1 stability and activity; mutations linked to muscular dystrophy [4,7] |
| DPM1 | Dolichol-phosphate mannose synthase subunit 1 | Regulates desmosomal adhesion and epidermal differentiation via SERPINB5 |
| DPM2 | Dolichol-phosphate mannose synthase subunit 2 | Stabilizes DPM1 and anchors complex to ER membrane |
| DPM3 | Dolichol-phosphate mannose synthase subunit 3 | Required for DPM complex assembly and function |
| PIG-M | GPI mannosyltransferase I catalytic subunit | Involved in GPI anchor biosynthesis; mutations cause GPI deficiency |
| PIG-X | GPI mannosyltransferase I accessory subunit | Stabilizes PIG-M and is required for mannosyltransferase activity |
| PimE | Mycobacterial mannosyltransferase | Involved in glycolipid biosynthesis and cell wall formation |
| DAG1 | Dystroglycan, substrate of Pmt1-Pmt2 complex | O-mannosylation is essential for sarcolemma resilience |
| FKRP | Fukutin-related protein, glycosyltransferase for dystroglycan | Mutations cause limb-girdle muscular dystrophy |
| LARGE1 | Glycosyltransferase that modifies dystroglycan | Cooperates with O-mannosylation to ensure muscle integrity |
| SERPINB5 | Serine protease inhibitor, downstream of DPM1 | Mediates DPM1 effects on desmosomal adhesion |
| ATM | ATM kinase, potential regulator of glycosylation pathways | ATM loss disrupts autophagy-lysosomal pathway, may affect glycosylation |
| PKD1 | Polycystin-1, associated with ADPKD | May interact with glycosylation pathways; model for ciliary signaling |
| TBEV proteins | Viral effectors that may modulate glycosylation | TBEV infection alters neuronal RNA profiles, potentially affecting mannosyltransferases |
How Is mannosyltransferase complex Regulated?
Mannosyltransferase complex activity is regulated by multiple mechanisms. Subunit expression levels control complex abundance; for example, DPM1 levels influence desmosomal adhesion and epidermal differentiation. Donor substrate availability, such as dolichyl phosphate mannose, is a key determinant of O-mannosylation rate. Post-translational modifications and interacting proteins may also modulate complex activity [4,6]. In pathogens, environmental signals regulate mannosyltransferase expression to adapt to host conditions [6,8].
mannosyltransferase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POMT1 | Walker-Warburg syndrome, muscular dystrophy | Pomt1 knockout mouse, patient iPSC-derived myotubes [4,7] |
| POMT2 | Muscular dystrophy | Pomt2 knockout zebrafish, CRISPR point mutations [4,7] |
| DPM1 | Epidermal differentiation disorder | Dpm1 knockout keratinocytes, skin organoids |
| PIG-M | GPI deficiency, fungal infection | PIG-M knockout yeast, Candida glabrata infection model |
| PimE | Mycobacterial cell wall biosynthesis | Mycobacterium smegmatis PimE knockout |
Muscular dystrophy and sarcolemma fragility
O-mannosylation of dystroglycan by the Pmt1-Pmt2 complex is essential for sarcolemma resilience and skeletal muscle health. Defects in this complex or its substrate cause congenital muscular dystrophies characterized by muscle weakness and membrane fragility. Knockout models of POMT1 and POMT2 exhibit severe dystrophic phenotypes, highlighting the importance of mannosyltransferase complexes in muscle [4,7].
Epidermal differentiation disorders
DPM1, a component of the dolichol-phosphate mannose synthase complex, modulates desmosomal adhesion and epidermal differentiation through SERPINB5. Disruption of DPM1 leads to impaired epidermal differentiation and skin barrier defects, linking mannosyltransferase complex function to skin disorders.
Fungal and mycobacterial pathogenesis
Mannosyltransferase complexes are critical for the virulence of fungal and mycobacterial pathogens. The Candida glabrata GPI mannosyltransferase I complex is essential for GPI anchor biosynthesis and cell wall integrity, making it a potential antifungal target. The mycobacterial PimE mannosyltransferase is involved in glycolipid biosynthesis and cell wall formation, representing a target for tuberculosis therapy.
From mannosyltransferase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of Pmt1-Pmt2? | Cryo-EM structure of Pmt1-Pmt2 complex |
| How does DPM1 affect epidermal differentiation? | DPM1 knockout keratinocytes and skin organoids |
| What is the role of O-mannosylation in muscle? | POMT1/POMT2 knockout mouse models |
| How does GPI mannosyltransferase I function? | Candida glabrata PIG-M/PIG-X knockout |
| What is the function of PimE in mycobacteria? | Mycobacterium smegmatis PimE knockout |
| How does ATM loss affect glycosylation? | ATM knockout cell lines |
How to Study the mannosyltransferase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of protein complexes | Determining architecture of Pmt1-Pmt2 and GPI mannosyltransferase I [4,6] |
| X-ray crystallography | Atomic structure of proteins | Resolving catalytic domains of mannosyltransferases |
| In vitro mannosyltransferase assay | Enzymatic activity | Measuring mannose transfer to acceptor substrates [4,8] |
| Mass spectrometry | Glycosylation sites and glycan structures | Identifying O-mannosylated proteins |
| CRISPR knockout | Gene function | Disrupting POMT1, DPM1, PIG-M to study phenotypes [5,6,7] |
| Co-immunoprecipitation | Protein-protein interactions | Isolating mannosyltransferase complex subunits [5,6] |
| RNA-seq | Transcriptional changes | Assessing glycosylation gene expression in disease models |
| Immunofluorescence | Subcellular localization | Localizing mannosyltransferase complexes to ER/Golgi [4,6] |
Structural biology (cryo-EM and X-ray crystallography)
Cryo-EM and X-ray crystallography have been used to determine the structures of mannosyltransferase complexes, including the Pmt1-Pmt2 complex and the Candida glabrata GPI mannosyltransferase I complex [4,6]. These methods reveal subunit architecture, substrate binding sites, and catalytic mechanisms, providing a basis for inhibitor design [4,6,8].
Glycosylation assays
In vitro mannosyltransferase assays using radiolabeled or fluorescent mannose donors measure the enzymatic activity of complexes [4,8]. These assays can be coupled with mass spectrometry to identify specific glycosylation sites on acceptor proteins.
Knockout and knockdown models
CRISPR-Cas9 knockout and RNA interference knockdown of genes encoding mannosyltransferase complex subunits reveal their cellular functions [5,7]. For example, POMT1 knockout cells show loss of dystroglycan O-mannosylation and impaired muscle cell adhesion.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry identifies subunits and interacting partners of mannosyltransferase complexes [5,6]. This approach has been used to define the composition of the DPM synthase complex and GPI mannosyltransferase I complex [5,6].
How CRISPR Can Be Used to Study GO:0031501 mannosyltransferase complex
Knockout
CRISPR-Cas9 knockout of genes encoding mannosyltransferase complex subunits, such as POMT1, POMT2, DPM1, or PIG-M, enables loss-of-function studies to determine their roles in glycosylation and disease [5,6,7]. Knockout cell lines and animal models reveal defects in protein O-mannosylation, GPI anchor biosynthesis, and epidermal differentiation [5,7].
Point Mutation
CRISPR-mediated point mutations can mimic patient-derived missense mutations in mannosyltransferase genes, allowing structure-function analysis and disease modeling [4,7]. For example, point mutations in POMT1 catalytic residues can abolish enzyme activity and reproduce muscular dystrophy phenotypes [4,7].
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous mannosyltransferase genes facilitates imaging and proteomic analysis of complex assembly and localization [4,6]. Tagged knock-in models can also be used to study subunit stoichiometry and dynamics.
Overexpression
Overexpression of mannosyltransferase complex subunits, such as DPM1 or POMT1/POMT2, can enhance glycosylation capacity and rescue loss-of-function phenotypes [5,7]. Overexpression models are useful for producing glycosylated proteins for structural and biochemical studies.
How EDITGENE Supports mannosyltransferase complex Research
Researchers studying mannosyltransferase complex-related genes often need to determine whether a candidate gene is causally involved in glycosylation, disease, or cellular phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models for functional validation.
Contact EDITGENE today to design your custom CRISPR model for mannosyltransferase complex research.
Frequently Asked Questions About mannosyltransferase complex
What is GO:0031501 mannosyltransferase complex?
GO:0031501 is a Gene Ontology cellular component term defined as a complex that possesses mannosyltransferase activity, catalyzing the transfer of mannose to acceptor molecules.
What genes are involved in mannosyltransferase complex?
Key genes include POMT1, POMT2, DPM1, DPM2, DPM3, PIG-M, PIG-X, and PimE, which encode subunits of various mannosyltransferase complexes [4,5,6,8].
What is the function of the Pmt1-Pmt2 complex?
The Pmt1-Pmt2 complex is a protein O-mannosyltransferase that transfers mannose to serine/threonine residues of target proteins, including dystroglycan, and is essential for muscle integrity [4,7].
How is mannosyltransferase complex linked to muscular dystrophy?
Defects in O-mannosylation of dystroglycan by the Pmt1-Pmt2 complex cause congenital muscular dystrophies characterized by sarcolemma fragility and muscle weakness.
What diseases are associated with DPM1?
DPM1, a component of the dolichol-phosphate mannose synthase complex, modulates desmosomal adhesion and epidermal differentiation; its dysfunction is linked to epidermal disorders.
What is the role of GPI mannosyltransferase I?
GPI mannosyltransferase I catalyzes the addition of mannose to phosphatidylinositol during GPI anchor biosynthesis, a process essential for anchoring many cell surface proteins.
How can I study mannosyltransferase complex using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the function of mannosyltransferase complex subunits in glycosylation and disease [4,5,7].
What methods are used to study mannosyltransferase complexes?
Common methods include cryo-EM, X-ray crystallography, in vitro enzymatic assays, mass spectrometry, and CRISPR-based genetic screens [4,6,8].
Is mannosyltransferase complex a drug target?
Yes, fungal and mycobacterial mannosyltransferase complexes are potential targets for antifungal and antimycobacterial drugs [6,8].
What is the substrate of mannosyltransferase complex?
Substrates include dolichyl phosphate mannose, GDP-mannose, proteins, lipids, and glycolipids, depending on the specific complex [4,6,8].
Conclusion
The mannosyltransferase complex (GO:0031501) is a functionally defined cellular component that catalyzes mannose transfer in diverse glycosylation pathways. Structural and genetic studies have revealed its essential roles in protein O-mannosylation, GPI anchor biosynthesis, and glycolipid assembly, with direct implications for muscular dystrophy, epidermal disorders, and infectious diseases [4,5,6,7,8]. Continued research using CRISPR models and advanced structural techniques will further illuminate the mechanisms and therapeutic potential of these complexes.
References
- 1. Cheng A et al.. 2021. ATM loss disrupts the autophagy-lysosomal pathway.. Autophagy 17(8):1998-2010 PMID: 32757690
- 2. Adam MP et al.. 1993. Polycystic Kidney Disease, Autosomal Dominant.. PMID: 20301424
- 3. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
- 4. Bai L et al.. 2019. Structure of the eukaryotic protein O-mannosyltransferase Pmt1-Pmt2 complex.. Nat Struct Mol Biol 26(8):704-711 PMID: 31285605
- 5. Rathod M et al.. 2024. DPM1 modulates desmosomal adhesion and epidermal differentiation through SERPINB5.. J Cell Biol 223(4) PMID: 38477878
- 6. Sun H et al.. 2025. Structural Insights into the Glycosylphosphatidylinositol Mannosyltransferase I Complex from Candida glabrata.. J Fungi (Basel) 11(11) PMID: 41295199
- 7. Hord JM et al.. 2025. Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan.. Skelet Muscle 15(1):1 PMID: 39789642
- 8. Liu Y et al.. 2025. Mechanistic studies of mycobacterial glycolipid biosynthesis by the mannosyltransferase PimE.. Nat Commun 16(1):3974 PMID: 40301322
